Response Letter to: Correspondence regarding the article by Murugan et al on Precision net ultrafiltration dosing in continuous kidney replacement therapy: a practical approach
- PMID: 38376597
- PMCID: PMC10879052
- DOI: 10.1186/s40635-023-00588-2
Response Letter to: Correspondence regarding the article by Murugan et al on Precision net ultrafiltration dosing in continuous kidney replacement therapy: a practical approach
Conflict of interest statement
RM, KK, and PMP filed an international patent application for the method of fluid removal described herein (Patent no. PCT/US2023/012204). RM received research grants from NIDDK and consulting fees from Baxter Inc., AM Pharma Inc., Bioporto Inc. and La Jolla Inc., unrelated to this study. KK received research grants NIDDK and from, Philips Research North America, and Google, a speaker honorarium from Nikkiso Critical Care Medical Supplies (Shanghai) Co., Ltd, and consulting fees to Mayo Clinic and from Baxter Inc.; PMP received consulting fees and advisory committee fees from Durect, Health-Span Dx, and Novartis; served on a Data and Safety Monitoring Board for Baxter; served as a member of an endpoint adjudication committee for GE Healthcare.
Similar articles
-
Correspondence regarding the article by Murugan et al. on "Precision net ultrafiltration dosing in continuous kidney replacement therapy: a practical approach".Intensive Care Med Exp. 2024 Feb 20;12(1):18. doi: 10.1186/s40635-023-00585-5. Intensive Care Med Exp. 2024. PMID: 38376740 Free PMC article. No abstract available.
-
Precision net ultrafiltration dosing in continuous kidney replacement therapy: a practical approach.Intensive Care Med Exp. 2023 Nov 28;11(1):83. doi: 10.1186/s40635-023-00566-8. Intensive Care Med Exp. 2023. PMID: 38015332 Free PMC article. No abstract available.
-
How to understand real net ultrafiltration and its association with low blood pressure in critically ill patients with renal replacement therapy.Crit Care. 2019 Jan 23;23(1):20. doi: 10.1186/s13054-018-2298-0. Crit Care. 2019. PMID: 30674339 Free PMC article.
-
Solute and Volume Dosing during Kidney Replacement Therapy in Critically Ill Patients with Acute Kidney Injury.Indian J Crit Care Med. 2020 Apr;24(Suppl 3):S107-S111. doi: 10.5005/jp-journals-10071-23391. Indian J Crit Care Med. 2020. PMID: 32704215 Free PMC article. Review.
-
Ultrafiltration in critically ill patients treated with kidney replacement therapy.Nat Rev Nephrol. 2021 Apr;17(4):262-276. doi: 10.1038/s41581-020-00358-3. Epub 2020 Nov 11. Nat Rev Nephrol. 2021. PMID: 33177700 Review.
Cited by
-
Protocolized fluid balance neutralization during continuous renal replacement therapy.Intensive Care Med. 2024 Dec;50(12):2141-2143. doi: 10.1007/s00134-024-07698-9. Epub 2024 Oct 31. Intensive Care Med. 2024. PMID: 39480517 No abstract available.
References
-
- Levey AS, Eckardt KU, Dorman NM, Christiansen SL, Hoorn EJ, Ingelfinger JR, Inker LA, Levin A, Mehrotra R, Palevsky PM, Perazella MA, Tong A, Allison SJ, Bockenhauer D, Briggs JP, Bromberg JS, Davenport A, Feldman HI, Fouque D, Gansevoort RT, Gill JS, Greene EL, Hemmelgarn BR, Kretzler M, Lambie M, Lane PH, Laycock J, Leventhal SE, Mittelman M, Morrissey P, Ostermann M, Rees L, Ronco P, Schaefer F, St Clair Russell J, Vinck C, Walsh SB, Weiner DE, Cheung M, Jadoul M, Winkelmayer WC. Nomenclature for kidney function and disease: report of a Kidney Disease: Improving Global Outcomes (KDIGO) Consensus Conference. Kidney Int. 2020;97:1117–1129. doi: 10.1016/j.kint.2020.02.010. - DOI - PubMed
-
- Raina R, Bedoyan JK, Lichter-Konecki U, Jouvet P, Picca S, Mew NA, Machado MC, Chakraborty R, Vemuganti M, Grewal MK, Bunchman T, Sethi SK, Krishnappa V, McCulloch M, Alhasan K, Bagga A, Basu RK, Schaefer F, Filler G, Warady BA. Consensus guidelines for management of hyperammonaemia in paediatric patients receiving continuous kidney replacement therapy. Nat Rev Nephrol. 2020;16:471–482. doi: 10.1038/s41581-020-0267-8. - DOI - PMC - PubMed
Publication types
LinkOut - more resources
Full Text Sources